Palisade Bio, Inc.
PALI
$2.14
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 500.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 500.00K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 500.00K | -- | -- | -- | -- |
| SG&A Expenses | 14.49M | 10.86M | 7.86M | 5.35M | 5.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.85M | 26.49M | 18.06M | 11.46M | 12.13M |
| Operating Income | -35.35M | -26.49M | -18.06M | -11.46M | -12.13M |
| Income Before Tax | -31.94M | -24.15M | -16.78M | -11.23M | -11.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.94 | -24.15 | -16.78 | -11.23 | -11.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.94M | -24.15M | -16.78M | -11.23M | -11.85M |
| EBIT | -35.35M | -26.49M | -18.06M | -11.46M | -12.13M |
| EBITDA | -35.35M | -26.49M | -18.05M | -11.45M | -12.13M |
| EPS Basic | -0.52 | -1.05 | -1.47 | -2.98 | -4.92 |
| Normalized Basic EPS | -0.33 | -0.66 | -0.92 | -1.86 | -3.07 |
| EPS Diluted | -0.52 | -1.05 | -1.47 | -2.98 | -4.92 |
| Normalized Diluted EPS | -0.33 | -0.66 | -0.92 | -1.86 | -3.07 |
| Average Basic Shares Outstanding | 634.09M | 427.51M | 222.64M | 19.23M | 13.25M |
| Average Diluted Shares Outstanding | 634.09M | 427.51M | 222.64M | 19.23M | 13.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |